πŸ‡ΊπŸ‡Έ FDA
Patent

US 8748573

Formulations comprising linaclotide

granted A61KA61K38/10A61K38/12

Quick answer

US patent 8748573 (Formulations comprising linaclotide) held by IRONWOOD PHARMACEUTICALS, INC. expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
IRONWOOD PHARMACEUTICALS, INC.
Grant date
Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/10, A61K38/12, A61K47/02, A61K47/36